AUTO-6-NG

N/A

Report date: 2024/05/11 18:36:09

Base Information

Drug NameAUTO-6-NG
Drug Alias NameAUTO6 - Next GeneratioAUTO6-NGAUTO6NGAUTO-6-NG
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionAnti-GD2
TargetsDisialoganglioside GD2
Therapy Area/IndicationsSmall Cell Lung CarcinomaSkin NeoplasmsNeuroblastoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity College London
China Registration ClassN/A

Develop Information

Active CompaniesAutolus Therapeutics PlcBiontech Se
Inactive CompaniesUniversity College London
Active IndicationsNeuroblastoma
Inactive IndicationsSmall Cell Lung CarcinomaSkin NeoplasmsOsteosarcoma

Other Information

ATC CodeN/A
Related LinksN/A